Amundi Has $2.53 Million Stake in Sabra Healthcare REIT, Inc. $SBRA

Amundi grew its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 143,389 shares of the real estate investment trust’s stock after buying an additional 6,457 shares during the period. Amundi’s holdings in Sabra Healthcare REIT were worth $2,531,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of SBRA. Ameriprise Financial Inc. grew its position in Sabra Healthcare REIT by 6.9% in the 4th quarter. Ameriprise Financial Inc. now owns 912,210 shares of the real estate investment trust’s stock worth $15,799,000 after purchasing an additional 58,919 shares during the last quarter. D. E. Shaw & Co. Inc. grew its position in Sabra Healthcare REIT by 749.3% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 221,992 shares of the real estate investment trust’s stock worth $3,845,000 after purchasing an additional 195,854 shares during the last quarter. Focus Partners Wealth grew its position in Sabra Healthcare REIT by 4.0% in the 4th quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust’s stock worth $360,000 after purchasing an additional 797 shares during the last quarter. Jefferies Financial Group Inc. acquired a new stake in Sabra Healthcare REIT in the 4th quarter worth $348,000. Finally, Lazard Asset Management LLC grew its position in Sabra Healthcare REIT by 44.2% in the 4th quarter. Lazard Asset Management LLC now owns 71,847 shares of the real estate investment trust’s stock worth $1,244,000 after purchasing an additional 22,019 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Trading Up 1.1%

Shares of SBRA stock opened at $19.13 on Friday. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a market capitalization of $4.59 billion, a P/E ratio of 25.17, a P/E/G ratio of 1.51 and a beta of 0.88. The firm has a 50-day moving average price of $18.68 and a 200 day moving average price of $17.95. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the firm posted $0.36 EPS. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio is presently 157.89%.

Analyst Ratings Changes

SBRA has been the topic of several research analyst reports. BMO Capital Markets raised their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th. Truist Financial lifted their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research report on Tuesday, September 2nd. JMP Securities lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Scotiabank lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research report on Monday, June 23rd. Finally, Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average target price of $20.71.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.